Cargando…
Mammary Cells with Active Wnt Signaling Resist ErbB2-Induced Tumorigenesis
Aberrant activation of Wnt signaling is frequent in human malignancies. In normal epithelial tissues, including the breast, Wnt signaling is active only in a subset of cells, but it is unknown whether this subset of Wnt signaling-active cells is at increased risk of carcinogenesis. We created transg...
Autores principales: | Bu, Wen, Zhang, Xiang, Dai, Hua, Huang, Shixia, Li, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827100/ https://www.ncbi.nlm.nih.gov/pubmed/24265712 http://dx.doi.org/10.1371/journal.pone.0078720 |
Ejemplares similares
-
Pathway pathology: the wnt and erbB mammary tumors
por: Rosner, A, et al.
Publicado: (2001) -
Krt6a-Positive Mammary Epithelial Progenitors Are Not at Increased Vulnerability to Tumorigenesis Initiated by ErbB2
por: Holloway, Kimberly R., et al.
Publicado: (2015) -
The glucose transporter GLUT1 is required for ErbB2-induced mammary tumorigenesis
por: Wellberg, Elizabeth A., et al.
Publicado: (2016) -
Selective Roles of E2Fs for ErbB2- and Myc-mediated Mammary Tumorigenesis
por: Wu, Lizhao, et al.
Publicado: (2013) -
ErbB2 enhances mammary tumorigenesis, oncogene-independent recurrence and metastasis in a model of IGF-IR-mediated mammary tumorigenesis
por: Campbell, Craig I, et al.
Publicado: (2010)